Anavex Life Sciences started at buy with stock fair value estimate of $10 at Janney Jun. 18, 2019 at 7:28 a.m. ET by Tomi Kilgore Anavex Life Sciences stock price target cut to $5 from $14 at Maxim Group Feb. 13, 2018 at 2:10 p.m. ET by Tomi Kilgore Anavex awarded gra...
JonesTrading analyst Soumit Roy raised his price target to $50. AVXL Investing News, Analysis, and Tips Jun 21, 2021 11:11 AM EDT Anavex Life Sciences Climbs on Progress With Rett Syndrome Drug Anavex Life Sciences shares climb as it reported Phase 2 progress with a treatment for the ...
Anavex price target raised to $42 from $40 at H.C. Wainwright 17d ago AVXL Company Announcements Anavex Life Sciences Faces Manufacturing Challenges Impacting Product Launch and Financial Stability 18d ago AVXL The FlyNordstrom family to take chain private: Morning Buzz ...
Soumit Roy had an $80 price target back in early 2022, but after the CTAD odds ratio debacle and rett failure, he slashed it to $15. Even after the EMA MAA filing and peer-reviewed papers, his price target remains unchanged at $15. 1 Reply Keep Last Read Share 👍️ 1 👎️...
7:02p Microsoft’s stock is at its lowest level in over a year. Why the selloff may be overdone. 6:51p I’m 69 and only have $121,000 in my 401(k). How can I repair the damage of the past? 6:49p My husband’s son struggled with addiction, yet he gave him his credit...
Their average price target for AVXL stock is $28.50, which represents a potential upside of 130.77% from current levels. See more AVXL analyst ratings Final Analysis on AVXL Anavex Life Sciences has wrapped up 2024 on a promising note, with its shares surging on news of significant strid...